Medical Marijuana, Inc. Subsidiary HempMedsŪ to Exhibit at 2018 Marijuana Business Conference in Las Vegas

Thursday, November 8, 2018 Alternative Medicine News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, Nov. 8, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis

company in the United States, announced today that subsidiary HempMedsŪ will exhibit its line of award-winning cannabidiol (CBD) hemp oil products at the Marijuana Business Conference (MJ Biz Con) on
Nov. 14-16
in Las Vegas.

MJ Biz Con, the largest cannabis conference in the world, is the preeminent conference to drive business deals and forge valuable connections with cannabis professionals in business today. The event will attract more than 20,000 cannabis professionals and 1,000 exhibitors at the Las Vegas Convention Center at 3150 Paradise Rd, Las Vegas, NV 89109.

"We are thrilled to exhibit at the premiere business to business networking event for the cannabis industry," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "With the demand for wholesale CBD at an all-time high, and overwhelming media interest in the cannabis industry after still more state victories in this week's midterm elections, we trust this event will be a huge success on all fronts."

HempMedsŪ was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. in 2012 -- and the first to both make CBD products available in bulk for U.S. consumers and provide high-quality CBD hemp oil to customers around the world. HempMedsŪ was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay. A new version of HempMedsŪ Active-Relief Roll-On topical product with five times the amount of CBD content will also be on display along with the company's full suite of CBD products at MJ Biz Con.

HempMedsŪ Spokesperson Nick Fishenden, a former pro-golfer who has been in the industry for over half a decade, will be in attendance to offer media interviews on the company's products and the many benefits of CBD.

"It's incredible have the opportunity to connect with media and other industry professionals at this year's Marijuana Business Conference," said HempMedsŪ Spokesperson Nick Fishenden. "As a former athlete who didn't have the opportunity to use CBD when competing, I hope to help spread awareness on how beneficial it can be for active on-the-go consumers who wish to feel and perform their best."

Visit HempMedsŪ at booth 4311 or contact to schedule an onsite product media rundown or interview with HempMedsŪ Spokesperson Nick Fishenden.

About HempMedsŪ

HempMedsŪ is a corporate portfolio company of Medical Marijuana, Inc. (OTC: MJNA) and the Company's exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.We are a company of firstsŪ. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew HardChief Executive OfficerCMW MediaP.


Cision View original content:

SOURCE Medical Marijuana, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store